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Abstract The MHC class I gene family of rhesus macaques
is characterised by considerable gene duplications. While a
HLA-C-orthologous gene is absent, the Mamu-A and in
particular the Mamu-B genes have expanded, giving rise to
plastic haplotypes with differential gene content. Although
some of the rhesus macaque MHC class I genes are known to
be associated with susceptibility/resistance to infectious
diseases, the functional significance of duplicated Mamu-A
and Mamu-B genes and the expression pattern of their
encoded proteins are largely unknown. Here, we present data
of the subcellular localization of AcGFP-tagged Mamu-A and
Mamu-B molecules. We found strong cell surface and low
intracellular expression for Mamu-A1, Mamu-A2 and Mamu-
A3-encoded molecules as well as for Mamu-B*01704,
Mamu-B*02101, Mamu-B*04801, Mamu-B*06002 and
Mamu-B*13401. In contrast, weak cell surface and strong
intracellular expression was seen for Mamu-A4*1403,
Mamu-B*01202, Mamu-B*02804, Mamu-B*03002, Mamu-
B*05704, Mamu-I*010201 and Mamu-I*0121. The different
expression patterns were assigned to the antigen-binding α1
and α2 domains, suggesting failure of peptide binding is
responsible for retaining ‘intracellular’ Mamu class I mole-
cules in the endoplasmic reticulum. These findings indicate a
diverse functional role of the duplicated rhesus macaque
MHC class I genes.
Keywords MHCclassI.Mamu-A.Mamu-B.Subcellular
localization.Macaca mulatta
Introduction
Rhesus macaques are frequently used as important animal
models for the study of human infectious and autoimmune
diseases, in transplantation studies, and vaccine develop-
ment. As is known from other species, also the rhesus
macaque MHC (Mamu) is associated with susceptibility and
resistance to infectious and autoimmune diseases (Goulder
and Watkins 2008; Sauermann et al. 2008; Vierboom et al.
2005). Significant progress has been made in the last years
in the analysis of such disease associations, yet many of the
various identified MHC class I genes have not been
functionally characterised. The reason for this may be that
the rhesus macaque MHC class I gene region is highly
prone to gene expansions and contractions. While genes
orthologous to HLA-E and HLA-F are present, rhesus
macaques show extensive duplications of class I genes that
are assigned to the MHC-A, MHC-B and MHC-G lineages
(Daza-Vamenta et al. 2004; Kulski et al. 2004; Otting et al.
2007; Otting et al. 2005). Four distinct Mamu-A and >20
distinct Mamu-B genes were described in Indian rhesus
macaques (Daza-Vamenta et al. 2004; Otting et al. 2007;
Otting et al. 2005). A strict orthologue of HLA-C is absent
from the rhesus macaque MHC and the duplicated Mamu-G
genes are pseudogenes (Daza-Vamenta et al. 2004). The
function of Mamu-G was likely replaced by duplicated
Mamu-AG genes that show characteristics of both Mamu-A
and Mamu-G (Boyson et al. 1997). Further contributing to
this complex genomic situation are highly variable numbers
of class I genes in rhesus macaque MHC class I haplotypes,
i.e., haplotypes show differential gene content. In addition,
the classical class I gene Mamu-A1 exhibits considerable
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although too much smaller extent as compared to classical
HLA class I genes. Blocks of repetitive elements in which
the single class I gene units are embedded (Bonhomme et
al. 2007; Bonhomme et al. 2008; Kulski et al. 2004)
substantially enhance unequal crossing-over events during
meiosis, giving rise to differences in gene content. Such
mechanisms are typical examples of ‘birth and death’
processes in MHC class I gene evolution (Nei et al. 1997).
Four and seven Mamu-A genes have been defined in
rhesus macaques of Indian and Chinese origin, respectively
(Blasky et al. 2008;K a r le ta l .2008;O t t i n ge ta l .2007;
Otting et al. 2005). These genes differ in their degrees of
polymorphism and in transcriptional activity. Whereas alleles
of the Mamu-A1 gene were so far found on every haplotype,
differential gene content is evident for Mamu-A2, Mamu-A3
and Mamu-A4, which are less polymorphic and transcribed
to lower extent (Otting et al. 2007). The Mamu-B subregion
displays even a higher degree of complexity, as shown by
genomic sequencing of a complete Mamu haplotype (Daza-
V a m e n t ae ta l .2004) and by cDNA cloning and segregation
studies in rhesus macaque families (Otting et al. 2005;O t t i n g
et al. 2008). Based on promotor and exon/intron structure
only 14 of the 19 Mamu-B genes of the sequenced haplotype
are expected to be transcribed, but only seven of them were
found by cDNA analysis. These genes also include the so-
called Mamu-I genes that are members of the Mamu-B gene
subfamily and were previously designated Mamu-B*09
(Urvater et al. 2000). Mamu-I genes are characterised by
low variability and low expression of their gene products on
the cell surface upon transfection (Urvater et al. 2000).
According to the number of clones found by cDNA cloning,
the transcribed Mamu-B genes are distinguished into ‘major
and minor expressors’ (Otting et al. 2008).
Data on protein expression of certain Mamu-A and most
Mamu-B molecules are largely lacking. Antigen presentation
has been extensively studied for Mamu-A1 alleles, in
particular for allele Mamu-A1*001, which confers slow
progression to AIDS and low viral loads upon experimental
infection with the simian immunodeficiency virus (SIVmac).
In addition, antigen presentation was described for Mamu-
B*001, B*003, B*008, B*012 and B*017 (Goulder and
Watkins 2008;H i c k m a n - M i l l e re ta l .2005; Loffredo et al.
2007; Mothe et al. 2002; Voss and Letvin 1996). Here, we
have established various expression constructs for Mamu-A
and Mamu-B molecules with a carboxy-terminal AcGFP tag
and studied their subcellular expression in MHC class I
negative K562 cells by confocal laser microscopy and flow
cytometry. We found classical surface expression for all
Mamu-A molecules except Mamu-A4*01403 and divergent
subcellular expression patterns for Mamu-B molecules. Our
dataindicatethatsomeMamu-B moleculesarenotloadedwith
peptides and therefore remain predominantly inside the cell.
Materials and methods
PBMC samples
Blood samples were obtained during regular veterinary
inspections of 30 Indian rhesus macaques housed in the
German Primate Centre. Peripheral blood mononuclear cells
(PBMC) were obtained after ficoll gradient centrifugation for
45 min.
RNA isolation, cDNA synthesis, RT-PCR and cloning
of MHC class I and B2M cDNA
All rhesus macaque PBMC samples were pooled and total
RNA was isolated with a Qiagen RNA Mini purification kit
(Qiagen, Hilden, Germany). Complementary DNA (cDNA)
was synthesised with oligo-dT primer and murine leukaemia
virus reverse transcriptase (M-MLV-RT) (Promega, Man-
nheim, Germany). Polymerase chain reaction (PCR) was
performed to amplify MHC class I cDNA and rhesus
macaque Β2M (mmB2M) cDNA using BioTherm Taq
DNA Polymerase (Genecraft, Cologne, Germany) with
primer pairs for Mamu-A (Mamu-A-EcoRI-forward:
GCTCGAATTCCAAGGATGGCGCCCCGAACCCT,
Mamu-A-BamHI-reverse: GATAAGGATCCTCCACTTTA
CAAGCCATAAGAGA), Mamu-B (Mamu-B-HindIII-
forward: GCTCAAGCTTCGGTCATGCGGGTCA
TGGCGCCCC, Mamu-B-KpnI-reverse: CGTAGGTACCT
TAGCCGTGAGAGACACATCA), Mamu-I (Mamu-I-
HindIII-forward: GCTCAAGCTTCGGTCATGCGGGT
CATGGCGCCCG, Mamu-I-KpnI-reverse: CGTAGGTACC
CAAGCTGTGAGAGACACATCAG), and mmB2M
(mmB2M-forward: CGAGATGTCTCGCTCAGTG,
mmB2M-reverse: TGACATGTCTCGATCCCACTT). HLA-
C-specific PCRwasperformedusingprimersHLA-C-HindIII-
forward: CATAAGCTTCGAGATGCGGGTCATGGCGC
and HLA-C-KpnI-reverse: GTAGGTACCTGGGCTTTA
CAAGCGATGAGAGACT. Restriction sites introduced in
primers for cloning of MHC class I cDNA in the expression
vector pAcGFP-N1 are underlined. PCRs were performed
with a Labcycler (SensoQuest, Göttingen, Germany) and
the following parameters were used: initial denaturation at
94°C for 4 min, 30 cycles of 94°C for 60 s (30 s for
mmB2M), 60°C (62°C for HLA-C) for 60 s (30 s for
mmB2M) and 72°C for 90 s (60 s for mmB2M), followed
by a final extension for 72°C for 5 min. PCR products
were analysed by agarose gel electrophoresis and purified
with the Wizard® SV Gel and PCR Clean-Up System
(Promega). MHC class I and mmB2M PCR products were
cloned in the pGEM-T Easy vector (Promega) and
pcDNA3.1/V5-His-TOPO TA expression vector (Invitro-
gen, Carlsbad, CA, USA), respectively. Isolated plasmids
were sequenced with BigDye terminator cycle sequencing
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automatic sequencer (Applied Biosystems, Foster City,
CA, USA). MHC class I cDNA clones with identical
sequences that were found at least three times were used
for subcloning in the pAcGFP-N1 expression vector
(Clontech, Carlsbad, CA, USA).
Establishment of chimeric and mutated Mamu class I
constructs
Chimeric constructs of Mamu-I*010201 and Mamu-
B*06002 were established by PCR, exchanging either
exon 2 or exon 3 or both exons. Forward and reverse
primers at the ends of exons 2 and 3 were constructed (α1
exchange F: GGGTCTCACACCCTCCAG; α1 exchange
R: GGAGGGTGTGAGACCCC; α1+α2 exchange F:
GGATCCCCCAAAGACACAC; α1+α2 exchange R:
CTTTGGGGGATCCGCGC). 5′ and 3′ part were ampli-
fied from Mamu-I*010201-AcGFP and Mamu-B*06002-
AcGFP constructs with one internal primer and one vector
primer (pAcGFP F: CAAATGGGCGGTAGGCGTG or
pAcGFP R: GTGGCCATTCACATCGCCAT) with proof-
reading Pfu DNA polymerase (Fermentas, Ontario, Can-
ada).Fortheexchangeoftheα2domain,theα1-exchanged
chimeric constructs were used as templates together with
the primers for the α1+α2 exchange. PCR products were
isolated after gel electrophoresis and used as templates for
the generation of chimeric constructs in a further PCR: five
cycles without and 25 cycles with pAcGFP vector primers.
Obtained PCR products were digested with restriction
enzymes EcoRI and KpnI and ligated into EcoRI/KpnI-
digested pAcGFP-N1 expression vector.
To establish untagged rhesus macaque MHC class I
molecules, the AcGFP tag was removed by site-directed
mutagenesis of the AcGFP start codon (AUG) into a stop
codon (UGA) in Mamu-A1*00101, Mamu-A1*00801,
Mamu-A1*01101, Mamu-A2*050402, Mamu-A3*1311,
Mamu-A4*1403, Mamu-B*01202, Mamu-B*02101, Mamu-
B*02804, Mamu-B*06002, Mamu-I*010201 and Mamu-
I*0121 expression constructs. Primers introducing the amino
acid change (without AcGFP F: CGGGATCCACCGGTCT
GAGTGAGCAAGGGCGCC; without AcGFP R:
GGCGCCCTTGCTCACTCAGACCGGTGGATCCCG)
were used with the QuikChange Multi Site-Directed Muta-
genesis Kit according to the manufacturer’s recommendations
(Stratagene, La Jolla, CA, USA). All chimeric or mutated
constructs were finally controlled by sequencing analysis.
Transfection of K562 cells, confocal microscopy and flow
cytometry
K562 cells (human erythromyeloid leukaemia, DSMZ,
Germany) were propagated in DMEM medium (PAA,
Pasching, Austria), supplemented with 10% inactivated
FCS, 100 U/ml penicillin and 0.1 mg/ml streptomycin
(PAA). Cells were split 1:3 to 1:5 every second or third day.
Cells were routinely tested for presence of mycoplasma
using 1 µl of cell culture supernatant as template in a PCR
with primers MYCF1: ACACCATGGGAGCTGGTAAT
and MYCR1: CTTCWTCGACTTYCAGACCCAAGG
CAT followed by a nested PCR with primers MYCF2:
GTTCTTTGAAAACTGAAT and MYCR2: GCATCCAC
CAWAWACTCT.
K562 cells were also transiently transfected using
Metafectene reagent according to manufacturer’s instruc-
tions (Biontex, Martinsried, Germany). Transfection effi-
ciency was controlled 48 h later by fluorescence
microscopy via AcGFP fluorescence.
K562 cells were transiently co-transfected with Mamu-B
and rhesus macaque B2M constructs as described above.
Expression of V5-tagged B2M was controlled in parallel
experiments with mouse anti-V5 monoclonal antibody
(Invitrogen) and goat anti-mouse IgG-PE-Cy5 polyclonal
antibody (Santa Cruz Biotechnology, Santa Cruz, CA,
USA).
Surface expression of MHC class I molecules was
verified by confocal microscopy and flow cytometry. Cells
(5 × 10
5) were washed twice with phosphate-buffered
saline (1 × PBS) and stained with the anti-MHC class I
monoclonal antibody W6/32 (hybridoma HB-95, ATCC) or
the anti-B2M monoclonal antibody BBM.1 (sc-13565,
Santa Cruz Biotechnology) for 1 h at 4°C. Binding of
W6/32 or BBM.1 was detected with a goat anti-mouse IgG-
PE-Cy5 polyclonal antibody (SC-3799, Santa Cruz Bio-
technology). For microscopy, cells were resuspended in
30 µl 1 × PBS and 10 µl were put on a slide and covered
with a cover slip. Pictures were taken immediately to ensure
that cells were still alive. All images were collected with
confocal laser scanning microscope LSM 5 PASCAL
(Zeiss) through ×63 objectives. Images were processed
with Photoshop CS software (Adobe, San Jose, CA, USA).
For flow cytometry, cells were resuspended in 200 µl of
1 × PBS and 30,000 events were measured in a LSR II flow
cytometer (BD Bioscience, San Jose, USA). Living cells
were gated based on forward and side scatter character-
istics. Data were acquired with BD FACS Diva 5.1
Software (Becton Dickinson) and subsequently analysed
with FlowJo 5.7.1 or 7.5.5 Software (TreeStar, Ashland,
OR, USA).
Co-localisation of AcGFP-tagged Mamu-A and Mamu-B
molecules with organelle-specific marker molecules
K562 cells were transiently transfected with Mamu-
A1*00101 or Mamu-B*01202 expression constructs and
grown for 48 h in 5% CO2 and 37°C. Cells were harvested
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2% paraformaldehyde for 10 min at room temperature.
After two rounds of washing with 1 × PBS, cells were
permeabilised with 0.5% Triton X-100 in 1 × PBS for
5 min at room temperature. Non-specific binding was
blocked by incubation with 5% bovine serum albumin
(BSA) in 1 × PBS for 30 min at room temperature.
Antibodies were diluted in 0.5% BSA in 1 × PBS for
detection of organelle markers; primary antibodies were
applied overnight at 4°C (anti-Calnexin, 1:1,000 (BD
Bioscience); anti-GM130 1:250 (BD Bioscience); and
anti-LAMP-1 1:25 (clone: H4A3, Developmental Studies
Hybridoma Bank, Iowa City, IA, USA)). After washing
twice with 1 × PBS, antibody staining was visualised by
incubation with a secondary antibody (polyclonal rabbit
anti-mouse-TRITC, DAKO, Glostrup, Denmark; 1:40) for
1 h at room temperature. Cells were washed twice with 1 ×
PBS followed by mounting with fluorescent mounting
medium (DAKO). Fluorescent cells were analysed with a
confocal laser scanning microscope LSM 5 PASCAL
(Zeiss) through×63 objectives.
Nomenclature and database accession numbers
Novel cDNA sequences were submitted to DDBJ/EMBL/
GenBank database: Mamu-B*01202 (GQ387655), Mamu-
B*01704 (GQ387656), Mamu-B*02101 (GQ387657),
Mamu-B*05704 (GQ387658), Mamu-B*02801
(GQ387659), Mamu-B*13401 (GQ387661), Mamu-
I*0121 (GQ387662). Sequences were also submitted to
the Immunopolymorphism Database IPD (Robinson and
Marsh 2007) and received official designations (http://
www.ebi.ac.uk/ipd/mhc/). As in the meantime numbers of
known Mamu-A1 alleles and Mamu-B sequences both
exceed 100, the Mamu-A1 allelic lineages and the various
Mamu-B sequences are distinguished by the first three
digits after the star, e.g., Mamu-A1*001 or Mamu-B*012,
which were previously designated Mamu-A1*01 (or Mamu-
A01), and Mamu-B*12.
Results and discussion
We isolated Mamu-A and Mamu-B cDNAs from a pool of
30 rhesus macaques of Indian origin by RT-PCR cloning.
Altogether, 17 different cDNAs were identified, of which
six belong to the Mamu-A and 11 to the Mamu-B/Mamu-I
lineages. Sixteen of these cDNA sequences were identical
(or nearly identical) to already published Mamu-A or
Mamu-B/Mamu-I sequences. One cDNA sequence was less
than 96% identical to any of the known rhesus macaque
MHC class I sequences, likely representing a new gene or
allele that received the designation Mamu-B*13401 from
the Immuno Polymorphism Database (IPD-MHC database).
We were interested in studying the cell surface expression
of the various Mamu-A and Mamu-B-encoded molecules.
As reactivity of many rhesus macaque MHC class I proteins
with mouse anti-human MHC class I monoclonal antibody
W6/32 is not known, we fused the MHC class I cDNA
sequences with AcGFP for visualisation in K562 cells. As
controls we included K562 cells transfected with AcGFP
and AcGFP-tagged HLA-Cw*0303, respectively.
Expression patterns of Mamu-A and Mamu-B molecules
Six Mamu-A molecules were included in our analysis: three
alleles of the polymorphic classical MHC class I gene
Mamu-A1 (A1*00101, A1*00801, A1*01101) and one allele
each of the less polymorphic Mamu-A2 (A2*050402),
Mamu-A3 (A3*1311)a n dMamu-A4 (A4*1403) genes.
Strong cell surface expression was observed with mono-
clonal antibody W6/32 for the three Mamu-A1 alleles and
for Mamu-A3*1311 with a mean fluorescence intensity
(MFI) between 540 and 843 (Fig. 1a) and to lower extend
for Mamu-A2*050402 (MFI: 326). Mamu-A4*1403
revealed the lowest surface expression (MFI: 105) among
all Mamu-A molecules. The same tendency in MFI values
was observed upon staining of the cells with the anti-β2-
microglobulin antibody BBM.1 (Fig. 1b), indicating that
lower MFI values reflect fewer MHC class I molecules on
the cell surface and not lower affinity of W6/32 antibody
for different Mamu-A molecules. Confocal microscopy of
the AcGFP-tagged Mamu-A molecules demonstrated that
A1, A2 and A3-encoded molecules are mainly found on the
cell surface, and only few molecules were detected inside
the cell (Fig. 1a). In contrast, Mamu-A4*1403 is found
mainly inside the cell. Notably, cell surface expression
pattern of the studied Mamu-A molecules roughly corre-
lates with known transcription levels of Mamu-A1 (high),
Mamu-A2 and Mamu-A3 (medium) and Mamu-A4 (low)
Fig. 1 Analysis of Mamu-A and Mamu-B protein expression. a K562
cells were transiently transfected with expression constructs encoding
AcGFP-tagged Mamu-A, Mamu-B or HLA-Cw*0303 or empty
AcGFP vector. The latter two served as controls. Confocal microsco-
py: left panels show AcGFP fluorescence, middle panels show
binding of monoclonal mouse anti-MHC class I antibody W6/32,
right panels show merge. Flow cytometry: green lines show binding
of W6/32, dotted grey lines are negative controls (empty AcGFP
vector) and dashed grey lines show secondary antibody control
(polyclonal PeCy5-coupled goat anti-mouse antibody). The mean
fluorescence intensity (MFI) is given in the upper right corner.
Results show one of at least three independent experiments. b AcGFP-
tagged Mamu-A and Mamu-B expression constructs were transiently
transfected in K562 and tested for binding of anti-MHC class I
monoclonal antibody W6/32 and anti-beta-2-microglobulin antibody
BBM.1 in flow cytometry. Relative binding is indicated as ratio of
MFI (W6/32 or BBM.1)/MFI (mock transfection). The average of
three independent experiments is shown and error bars denote SEM
b
152 Immunogenetics (2010) 62:149–158c
e
l
l
 
c
o
u
n
t
s
W6/32 (log)
Mamu-B*01202
Mamu-B*03002
Mamu-B*05704
Mamu-B*01704
Mamu-B*04801
Mamu-B*06002
Mamu-B*13401
Mamu-B*02804
Mamu-I*0121
Mamu-B*02101
Mamu-I*010201
100
411
110
114
792
147
222
159
585
737
132
a AcGFP MHC class I merge
Mamu-A1*00101
Mamu-A1*00801
Mamu-A1*01101
Mamu-A3*1311
Mamu-A4*1403
Mamu-A2*050402
843
611
820
326
540
HLA-Cw*0303
AcGFP
1219
58
105
b
01 0 2 0 3 0 4 0 5 0
MOCK
A1*00101
A1*00801
A1*01101
A2*050402
A3*1311
A4*1403
B*01202
B*01704
B*02101
B*02804
B*03002
B*04801
B*05704
B*06002
B*13401
I*010201
I*0121
relative binding of W6/32 and BBM.1
Immunogenetics (2010) 62:149–158 153according to data published by Otting and colleagues
(2007).
From our cDNA pool we cloned nine Mamu-B and two
Mamu-I cDNAs. Only one of these cloned Mamu-B cDNA
sequences (Mamu-B*03002) is identical with a gene of the
completely sequenced MHC class I haplotype (accession
no. AB128049; Mamu-B5). All other cloned sequences are
either alleles from already known Mamu-B genes or
represent distinct genes. Analysis of the various Mamu-B-
transfected K562 cells by flow cytometry and confocal
microscopy also revealed different protein expression pat-
terns. Among all Mamu-B transfectants, B*01704, B*02101,
B*04801, B*06002 and B*13401 showed the highest level
of cell surface expression according to binding of W6/32,
with MFI values ranging between 222 and 792 (Fig. 1a).
Cell surface expression of these Mamu-B molecules is
comparable to Mamu-A-encoded class I molecules (except
Mamu-A4*1403) regarding quantity (MFI range) and quality
(confocal microscopy). Also similar to Mamu-A molecules is
a rather low level of intracellular expression of these Mamu-
B molecules, although B*01704 and B*06002 display some
intracellular AcGFP fluorescence. A second group of Mamu-
B molecules, B*01202, B*02804, B*03002, B*05704,
I*010201 and I*0121 are characterised by weak surface
expression with MFI values ranging between 100 and 159
and strong intracellular expression similar to what was found
for Mamu-A4*1403 (Fig. 1a). The same tendency in all
Mamu-B MFI values was observed upon staining of the cells
with the anti-β2-microglobulin antibody BBM.1 (Fig. 1b).
Thus, B*01704, B*02101, B*04801, B*06002 and B*13401
show protein expression levels similar to classical class I
molecules and B*01202, B*02804, B*03002, B*05704,
I*010201 and I*0121 to non-classical ones.
Otting and colleagues (2005) distinguished Mamu-B
genes as ‘majors’ and ‘minors’ according to mRNA
transcription levels and speculated that they are classified
accordingly as classical and non-classical MHC class I
genes. The classification as ‘major’ (classical class I) only
partially overlaps with our protein expression data:
B*01704, B*02101, B*04801 and B*06002. However, we
also found disagreeing results as B*01202,B * 02804 and
B*03002 are classified as ‘majors’ with respect to transcrip-
tion, but are characterised by a very low cell surface and
mainly intracellular expression pattern more compatible with
a non-classical MHC class I protein. This incongruence
might be due to post-transcriptional and post-translational
regulatory mechanisms such as RNA interference, inefficient
protein translation, or increased protein degradation, respec-
tively. Hence, mRNA transcription level might not necessar-
ily be a highly reliable predictor of cell surface protein
expression or classical/non-classical characters.
Although we did not analyse multiple alleles of single
rhesus macaque MHC class I genes, we do not expect
allelic differences to drastically change the protein expres-
sion pattern. This assumption is based on the fact that MHC
class I allelic polymorphism is generally low in rhesus
macaques (Otting et al. 2005), but also reflects to a certain
extent our limited knowledge of many Mamu-B sequences
whether they represent alleles or distinct genes. Therefore,
we cannot exclude the possibility that allelic differences are
indeed associated with changes of cellular expression
patterns.
Intracellular localization of rhesus macaque class I
molecules is due to ER retention
The construction of GFP fusion proteins is a well-
established method to visualise expression and to determine
subcellular localization of target molecules, especially if
specific antibodies are not available. In previous studies,
GFP-tagged HLA class I proteins were shown to behave in
a similar manner as their wild-type counterparts (Gromme
et al. 1999). Nevertheless, to exclude any potential effect of
the AcGFP tag, a stop codon was introduced by site-
directed mutagenesis in expression constructs A1*00101,
A1*00801, A1*01101, A2*050402, A3*1311, A4*1403,
B*01202, B*02101, B*02804, B*06002, I*010201 and
I*0121. No significant differences between tagged and
untagged Mamu class I molecules were observed (Fig. 2a),
ruling out a negative effect of AcGFP-tagging on MHC
class I cell surface expression. Availability of β2-
microglobulin is a regulating factor of cell surface
expression of many, but not all MHC class I molecules
(Myers et al. 1996). To rule out that inefficient binding of
human β2-microglobulin and unavailability of rhesus
macaque β2-microglobulin leads to lower expression levels
of some Mamu-B molecules on the surface of human K562
cells, we transiently co-transfected rhesus macaque B2M
along with two high expressing (B*01704, B*06002) and
three low expressing constructs (B*01202, B*02804,
I*010201). As is shown in Fig. 2b, presence of rhesus
macaque β2-microglobulin has no significant effect on cell
surface expression of all studied Mamu-B molecules. Thus,
we can exclude the AcGFP tag and unavailability of rhesus
macaque B2M as influencing factors of variable Mamu-B
expression patterns in K562 cells.
Peptide receptive class I molecules are usually retained
in the ER (Bijlmakers and Ploegh 1993) due to improper
folding, lack of glycosylation, or failure of peptide loading.
However, misfolded or empty class I molecules are not
completely retained in the ER, they can cycle between the
cis-Golgi, the intermediate compartment and the ER
(Garstka et al. 2007; Hammond and Helenius 1994). Hence,
we studied by confocal microscopy the intracellular
distribution of AcGFP-tagged A1*00101 and B*01202
(Fig. 3) as well as B*06002 and I*010201 (not shown) by
154 Immunogenetics (2010) 62:149–158co-staining transfected K562 cells with markers for intra-
cellular compartments. For both Mamu-A1*00101 (Fig. 3)
and Mamu-B*06002 (not shown) partial co-localisation
with Golgi marker GM130 and with late endosomal/
lysosomal marker LAMP-1 can be seen, but is not visible
with ER marker calnexin, indicating transport through
Golgi apparatus, recycling of A1*00101 and B*06002
from cell surface to lysosomes, and fast egress from ER,
respectively. Such intracellular staining pattern was
expected for cell surface-expressed MHC class I molecules
(Gromme et al. 1999). The intracellularly expressed MHC
class I molecules B*01202 (Fig. 3) and Mamu-I*010201
(data not shown) show the opposite pattern: co-localisation
with calnexin, but not with GM130 or LAMP-1. We
conclude from these findings that the intracellularly
expressed Mamu-B and Mamu-I molecules are retained
within the ER.
Differential expression patterns can be assigned to the α1
and α2 domains
Intracellular localisation of MHC class I molecules was
described for HLA-C and is due to inefficient assembly,
A1*00101
A1*00101
A1*00101
B*01202
B*01202
B*01202
α  -Calnexin
α  -GM130
α  -LAMP-1
α  -Calnexin
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Fig. 3 Co-localisation of AcGFP-tagged Mamu-A1*00101 and
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Fig. 2 AcGFP-tagging and presence of rhesus macaque β2-
microglobulin do not affect the surface expression of rhesus macaque
MHC class I molecules. a Constructs coding for Mamu-A1*00101,
A1*00801, A1*01101, A2*050402, A3*1311, A4*1403, B*01202,
B*02101, B*02804, B*06002, I*010201 and I*0121 either with or
without C-terminal AcGFP were transiently transfected in K562 cells.
Surface expression was measured 2 days post-transfection by flow
cytometry with W6/32 and polyclonal PeCy5-coupled goat anti-mouse
antibody. The MFI ratios of AcGFP-tagged versus untagged MHC
class I of four independent experiments are indicated. Horizontal bars
indicate the average and vertical bars denote SEM. b K562 cells were
transiently transfected with AcGFP-tagged Mamu-B constructs along
with either none (control), 2 µg, or 3 µg of rhesus macaque β2-
microglobulin expression construct (mmB2M). Expression of
mmB2M was controlled in parallel experiments with anti-V5 tag-
specific antibody. The average of three independent experiments is
shown and error bars denote SEM
Immunogenetics (2010) 62:149–158 155slower intracellular transport and stronger association with
the TAP complex compared to HLA-A and HLA-B (Neisig
et al. 1998; Sibilio et al. 2008). Mutation of single amino
acid residues revealed that cysteine residues in the
cytoplasmic tail of certain HLA-B and HLA-C alleles are
crucial for cell surface expression (Gruda et al. 2007).
However, such amino acid residues or corresponding
differences in cytoplasmic tails of ‘high’ or ‘low’ cell
surface expressors are not found in Mamu-B molecules (not
shown), suggesting that the extracellular part, in particular
the α1a n dα2 domains, might be responsible for
differential expression patterns of Mamu-B molecules. We
tested this hypothesis by using chimeric expression con-
structs (Fig. 4a) where we exchanged exons 2 and 3 and
chose Mamu-B*06002 and Mamu-I*010201 as representa-
tives of high cell surface and high intracellular expression,
respectively. The chimeric molecule carrying the α1 and α2
domains of B*06002 and the C-terminal part of I*010201
was well expressed on the cell surface like the parental
B*06002 (Fig. 4b). Thus, the expression pattern is
determined by the α1 and α2 domains and not by the α3
domain or transmembrane and cytoplasmic regions. Similar
results were obtained for the chimaera with the α1 and the
α2 domains derived from I*010201 and the C-terminus
from B*06002, showing the same expression pattern as the
parental I*010201 (Fig. 4b). The observed expression
patterns can neither be assigned to the α1 nor the α2
domain alone. Exchange of either domain alone resulted in
a substantial reduction of MHC class I cell surface
expression in almost all cases, which might be due to
lower stability of chimeric molecules. An exception is the
α2 domain of B*06002 that conferred a slightly enhanced
cell surface expression in the context of an I*010201
framework, although still not achieving parental B*06002
MFI values (Fig. 4b). We conclude from these observations
that the peptide-binding groove is responsible for the
observed differences in subcellular localization and
hypothesise that Mamu-A and Mamu-B molecules with
low or nearly absent cell surface expression are not
efficiently loaded with peptides and therefore, are retained
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Fig. 4 Subcellular localization
of Mamu-B molecules can be
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domains. a Scheme of chimeric
constructs. The chimeric con-
structs of Mamu-I*010201 and
Mamu-B*06002 are named
according to the exchanged
domains (α1, α2o rα1 and α2
domains together). SP signal
peptide, TM/CT transmembrane
region and cytoplasmic tail,
AcGFP Aequorea coerulescens
green fluorescent protein. b
K562 cells were transiently
transfected and analysed with
W6/32 monoclonal antibody
and secondary goat anti-mouse
Pe-Cy5-coupled antibody 2 days
post-transfection by flow
cytometry. Lower panel shows
confocal laser microscopy (×63
magnification) merged images
of AcGFP-tagged Mamu class I
molecules (green) and W6/32
(red). Numbering allows for
rapid identification of the
respective constructs shown in
(a). All experiments were
performed at least three times
with similar results and a repre-
sentative experiment is shown
156 Immunogenetics (2010) 62:149–158in the ER. These Mamu-B molecules might preferentially
bind rare peptides that are available only in certain
physiological or pathological situations, finally resulting
in ER release and cell surface expression, analogous to
what was previously demonstrated for mouse non-classical
H2-M3 (Chiu et al. 1999). In accordance with this
hypothesis, the intracellularly expressed Mamu-B*012 is
known for its rather uncommon peptide-binding anchor
residue at position P2 (Hickman-Miller et al. 2005).
However, even very small amounts of cell-surface MHC
class I can be sufficient for CTL recognition as demon-
strated in a recent paper by Dressel and colleagues (2009),
showing highly efficient CTL-mediated and peptide-
dependent killing of multipotent adult germ-line stem cells
that appeared MHC class I negative in flow cytometry
analysis. Hence, also rhesus macaque MHC class I
molecules with limited amounts on the cell surface might
contribute to antigen presentation function. Indeed, the
weakly expressed Mamu-B*012 was previously shown to
present a SHIV-derived peptide to rhesus macaque CTLs
(Voss and Letvin 1996). The obvious functional signifi-
cance of lowly expressed MHC class I molecules raises an
important immunological question: how can rhesus mac-
aques back up a sufficiently broad T cell receptor repertoire
during thymic selection despite facing a plethora of
different MHC class I proteins? The key to that enigma
may lie in macaques’ strategy of MHC diversity: low allelic
polymorphism and high haplotypic diversity in terms of
copy number variations. This strategy fits well with the
recent finding of inherited control of thymic selection by
germ-line-encoded amino acids of the T cell receptor
(Scott-Browne et al. 2009). A further explanation for
occurrence of intracellular class I molecules of rhesus
macaques might be adaptation to certain viral infections
and viral subversions of the class I antigen presentation
machinery by ‘spamming’ the ER with different types of
MHC class I molecules, thereby reducing the probability of
viral immune evasins to down-regulate classical rhesus
macaque MHC class I proteins. Nevertheless, our data
clearly demonstrate that many of the rhesus macaque class I
molecules show an unexpected subcellular localization and
this indicates functional diversification of the duplicated
genes. Future functional studies have to clarify the role of
the intracellularly expressed MHC class I proteins and
should help to explain disease associations of certain rhesus
macaque MHC class I haplotypes.
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